<DOC>
	<DOCNO>NCT01550653</DOCNO>
	<brief_summary>This study examine hypothesis , subcutaneous administration liraglutide , analogue incretin glucagon-like peptide 1 , 5 week improve memory function healthy human .</brief_summary>
	<brief_title>Liraglutide Effects Memory Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Male sex Age 1835 year Body mass index 19 25 kg/m2 Nonsmoker Receipt drug within 4 week prior trial Any known acute chronic disease brain , heart , lung , kidney , liver , pancreas gastrointestinal tract , metabolic , endocrine psychiatric disease . Brady Tachycardia , i.e . heart rate &lt; 50 &gt; 90 beat per minute . Hypertension ( systolic blood pressure &gt; 150 mmHg , diastolic blood pressure &gt; 90 mmHg ) . Hyperlipidemia ( cholesterol , LDL , triglyceride &gt; two time upper reference limit base analysis central laboratory ) Impaired hepatic function measure alanine aminotransferase ( ALAT ) &gt; two time upper reference limit base analysis central laboratory Impaired renal function measure creatinine &gt; 120 Âµmol/l base analysis central laboratory Family history diabetes History eat disorder Known suspect allergy trial product History drug alcohol abuse within last five year prior screen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Memory</keyword>
	<keyword>GLP-1</keyword>
	<keyword>Liraglutide</keyword>
	<keyword>energy output</keyword>
	<keyword>Memory facilitation</keyword>
	<keyword>GLP-1 analogue</keyword>
</DOC>